Kidney Measures and Venous Thromboembolism
Dr. Zhong Zheng provides an overview of his study, "Association of Estimated Glomerular Filtration Rate and Albuminuria with Venous Thromboembolism," on behalf of his colleagues.
Clinical Journal of the American Society of Nephrology (CJASN)
Clinical Journal of the American Society of Nephrology (CJASN) publishes high quality research relevant to clinical nephrology. Now one of the most widely-read and referenced kidney journals, physicians read CJASN to learn about the most important advances in clinical and translational research in nephrology.
en-us178 Episodes
People also ask
What is the main theme of the podcast?
Who are some of the popular guests the podcast?
Were there any controversial topics discussed in the podcast?
Were any current trending topics addressed in the podcast?
What popular books were mentioned in the podcast?
Episodes (178)
Participant Experience in the KPMP - Spanish Language
Drs. Angela Maria Victoria-Castro and Celia Pamela Corona-Villalobos summarize the findings from their study, "Participant Experience with Protocol Research Kidney Biopsies in the Kidney Precision Medicine Project," in Spanish.
Participant Experience in the KPMP
Drs. Angela Maria Victoria-Castro and Celia Pamela Corona-Villalobos summarize the findings from their study, "Participant Experience with Protocol Research Kidney Biopsies in the Kidney Precision Medicine Project," in English.
Resveratrol in CKD
Dr. Diana I. Jalal and Colin Gimblet discuss the findings of their study, "Effect of Resveratrol on Endothelial Function in Patients with CKD and Diabetes: A Randomized Controlled Trial," on behalf of their colleagues.
Tubular Biomarkers and Kidney Histopathology in Diabetes
Dr. Christine Limonte summarizes the main findings from her study "Associations of Biomarkers of Tubular Injury and Inflammation with Biopsy Features in Type 1 Diabetes," on behalf of her colleagues.
Metabolomics and Neurocognition
Dr. Arthur M. Lee provides an overview of the results of his study, "Circulating Metabolomic Associations with Neurocognitive Outcomes in Pediatric CKD," on behalf of his colleagues.
Clinical Journal of the American Society of Nephrology (CJASN)
en-usNovember 17, 2023
Interstitial Eosinophilic Aggregates Predict Kidney Failure
Dr. Hattori Koki discusses the results of his study, "Interstitial Eosinophilic Aggregates and Kidney Outcome in Patients with CKD," on behalf of his colleagues.
Nurse Practitioner Care in CKD
Dr. Matthew James, Ellen Novak, and Tayler Scory summarize the results of their study, "Nurse Practitioner Care Compared to Primary Care or Nephrologist Care in Early CKD," on behalf of their colleagues.
C3G Ig-MPGN and Complement Rare Variants
Drs. Marie-Sophie Meuleman and Sophie Chauvet provide a summary of their study, "Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative Glomerulonephritis," on behalf of their colleagues.
Cardiovascular Prevention in CKD
Dr. Reza Malekzadeh gives an overview of the results of his article "Fixed-Dose Combination Therapy for Prevention of Cardiovascular Diseases in CKD: An Individual Participant Data Meta-Analysis," on behalf of his colleagues.
An Interview with Tristan de Nattes, the Second-Place Winner of the 2023 CJASN Trainee of the Year Competition
CJASN Editor-in-Chief Rajnish Mehrotra interviews Tristan de Nattes, the 2023 CJASN Trainee of the Year second-place winner, on his article, "A Simple Molecular Tool for the Assessment of Kidney Transplant Biopsies."
An Interview with Rosa D. Wouda, the First-Place Winner of the 2023 CJASN Trainee of the Year Competition
CJASN Editor-in-Chief Rajnish Mehrotra interviews 2023 CJASN Trainee of the Year winner Rosa D. Wouda on her article, "Kaliuresis and Intracellular Uptake of Potassium with Potassium Citrate and Potassium Chloride Supplements."
HPA Axis Suppression in Nephrotic Syndrome
Dr. Rajiv Sinha discusses the findings from his study, "HPA Axis in Single- versus Divided-Dose Prednisolone for First Episode Nephrotic Syndrome: An Open Label RCT," on behalf of his colleagues.
PLA2R Antibodies and Treatment Response
Drs. Daniel Cattran and Sean Barbour summarize the main results of their study, "Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy," on behalf of their colleagues.
eGFRcys and eGFRcr Discrepancy
Dr. Morgan Grams provides an overview of the findings of her study, "Discrepancies between Cystatin C–Based and Creatinine-Based Estimated Glomerular Filtration Rates," on behalf of her colleagues.
Dasatinib Nephrotoxicity and Pharmacokinetics
Drs. Benjamin Adegbite and Evren Azeloglu discuss the results of their study, "Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity," on behalf of their colleagues.
Timing KRT in Children and Young Adults
Dr. Nick Larkins discusses the findings of his study, "Timing of Kidney Replacement Therapy among Children and Young Adults," on behalf of his colleagues.
COVID-19–Associated AKI
Dr. Farrukh M. Koraishy summarizes the results of his study, "Geographic and Temporal Trends in COVID-Associated Acute Kidney Injury in the National COVID Cohort Collaborative," on behalf of his colleagues.
ICI-Induced Kidney Adverse Events
Dr. Gangadharan Komala provides a summary of the results of his study, "Kidney Adverse Events Associated with Immune Checkpoint Inhibitor Therapy," on behalf of his colleagues.
Nirmatrelvir/Ritonavir in Kidney Transplant Patients
Mr. Pierre Giguère and Dr. Swapnil Hiremath provide an overview of their study, "Management and Outcome of COVID-19 Infection Using Nirmatrelvir/Ritonavir in Kidney Transplant Patients," on behalf of their colleagues.